US Activist Hedge Fund Institutional SEC 13D 13G — August 21, 2026

21-08-2026

Primary Development Fund (Cayman) SPC - E3 Fund SP and related entities disclosed a 5.3% beneficial ownership stake in CDT Equity Inc. (CDTTW) as of May 31, 2026, holding 41,673 shares of common stock. The filing is a Schedule 13G, indicating passive investment intent, and the ownership percentage is based on 786,670 shares outstanding as of August 12, 2026. The filing also notes two reverse stock splits (1-for-25 in March 2026 and 1-for-10 in July 2026) that affected the share count.

• · The filing is a Schedule 13G, filed under Rule 13d-1(c), indicating passive investment intent.
• · The reporting persons disclaim beneficial ownership of the shares reported.
• · The shares are held directly by Primary Development Fund on behalf of E3 Fund, a segregated portfolio.
• · E2 Trust holds 95% beneficial interest in E3 Fund; Altug Family Trust holds 5%.
• · IALC Trustees exercises sole voting and dispositive power over the shares.
• · The company's common stock has a par value of $0.0001 per share.
• · The company was formerly known as Conduit Pharmaceuticals Inc. (name change on September 22, 2023) and Murphy Canyon Acquisition Corp. (name change on November 30, 2021).

21-08-2026

AJB Investment Fund II, LP and related parties filed an amended Schedule 13D disclosing collective beneficial ownership of 467,247 shares (13.27%) of Jewett Cameron Trading Co Ltd as of August 20, 2026. The filing details recent open-market purchases by the group, with aggregate purchase prices of approximately $800,685 for the fund's 375,067 shares and additional personal holdings by Adam Bradley and Melinda Bradley. The reporting persons state they believe the shares were undervalued and may increase or decrease their position depending on market conditions, but have no present plans for major corporate changes.

• · The filing is an amendment (Schedule 13D/A) filed on August 21, 2026.
• · Recent open-market purchases occurred between July 21, 2026 and August 21, 2026 at prices ranging from $2.45 to $2.91 per share.
• · AJB Capital, LLC is the general partner of AJB Fund II and may be deemed beneficial owner of the same 375,067 shares.
• · Adam Bradley holds 33,159 shares in individual retirement accounts with sole voting and dispositive power.
• · The reporting persons have no present plan for any of the matters in Item 4 of Schedule 13D (e.g., mergers, asset sales, board changes).
• · A Joint Filing Agreement was entered into on May 18, 2026.

21-08-2026

White River Ventures LLC filed a Schedule 13G correcting an erroneous prior Schedule 13D filing for its holdings in Royalty Management Holding Corp. As of the filing, White River Ventures LLC beneficially owns 855,196 shares of Class A Common Stock, representing approximately 6.0% of the outstanding shares. The filing clarifies that the securities were acquired and are held in the ordinary course of business, without the purpose of changing control of the issuer.

• · The previous Schedule 13D, filed on November 8, 2023, was made in error, and the reporting person is eligible to file under Rule 13d-1(c).
• · White River Ventures LLC's business address is 8500 E. 116 Street, Unit 264, Fishers, IN 46038.
• · The filing date is August 21, 2026, and the date of change is also August 21, 2026.
• · The security title is Class A Common Stock, par value $0.0001, CUSIP 02369M102.

21-08-2026

C/M Capital Partners, LP and related entities disclosed a 9.99% beneficial ownership stake in Catheter Precision, Inc. (VTAK) as of August 16, 2026, holding 1,597,328 shares of common stock (including 159,574 shares issuable upon conversion of convertible preferred stock). The filing is a routine Schedule 13G under Rule 13d-1(c), indicating passive investment intent without control influence.

• · The filing is a Schedule 13G, not 13D, indicating passive investment intent without plans to influence control.
• · The reporting persons include C/M Capital Partners, LP as investment manager to the Funds, with Thomas Walsh and Jonathan Juchno as managing members of the general partner.
• · The business address for all reporting persons is 1111 Brickell Ave, Suite 2920, Miami, FL 33131.
• · The filing date is August 21, 2026, with the beneficial ownership effective as of August 16, 2026.

21-08-2026

Steamboat Capital Partners, LLC and its managing member Parsa Kiai filed an amended Schedule 13D with the SEC, reporting a 7.1% beneficial ownership stake in Medifast Inc. (MED) as of August 20, 2026, through the acquisition of 790,693 common shares at an aggregate cost of approximately $8,360,835. The filing also discloses recent open-market purchases of 33,994 shares on August 19, 2026, at a weighted average price of $11.66 per share, and 50,000 shares on August 20, 2026, at $11.60 per share, indicating ongoing accumulation by the fund. The holdings are held on behalf of clients, with Steamboat Capital acting as investment adviser.

• · Shares acquired at an aggregate price of approximately $8,360,835 (excluding commissions) via open market purchases.
• · On August 19, 2026, purchased 33,994 shares at a weighted average price of $11.66 per share (range: $11.56 - $11.80).
• · On August 20, 2026, purchased 50,000 shares at a weighted average price of $11.60 per share (range: $11.46 - $11.77).
• · Total shares outstanding as of July 27, 2026: 11,180,703 (per Medifast's Q2 2026 10-Q filed August 3, 2026).
• · Steamboat Capital Partners is a Delaware limited liability company and serves as investment adviser to its clients, including affiliated investment funds.
• · Parsa Kiai may be deemed to beneficially own the shares by virtue of his role as managing member of the investment adviser.

21-08-2026

In Amendment No. 1 to Schedule 13D, Chairman Dingxin Sun added himself as a Reporting Person alongside his wholly-owned Decent Limited, disclosing beneficial ownership of 921,040 Ordinary Shares (41.58% of shares, ~90.50% of voting power) in Decent Holding Inc. The filing details a dual-class structure and recent transactions, including a May 2026 subscription for 400,000 Class B shares at $2.00 per share and a 1-for-25 reverse share split in March 2026. The Reporting Persons intend to maintain control and continue active management, with no plans for major corporate changes.

• · Mr. Sun's ownership includes 321,040 Class A Ordinary Shares (indirect) and 600,000 Class B Ordinary Shares (200,000 indirect, 400,000 direct).
• · Class B Ordinary Shares carry 20 votes per share, while Class A shares carry 1 vote per share; Class B shares are convertible into Class A on a one-to-one basis.
• · The filing adds Mr. Sun as a Reporting Person; Decent Limited was previously the sole filer.
• · On March 16, 2026, the company effected a 1-for-25 reverse share split.
• · On July 14, 2026, shareholders approved an increase in authorized share capital from US$50,000 to US$2,500,000.
• · The Reporting Persons disclaim status as a 'group' for purposes of Schedule 13D/A.
• · No transactions in the reported securities were effected during the past 60 days other than those described in the filing.

21-08-2026

Brown Brothers Harriman & Co and its affiliate Brown Brothers Harriman Credit Partners, LLC filed a Schedule 13D/A indicating their aggregate beneficial ownership of 1,870,198.22 Class S Units in AMG BBH Asset-Backed Credit Fund, LLC, representing a 54.81% stake. The filing covers the acquisition of additional units by the Reporting Persons on August 19 and 20, 2026. No negative or flat metrics are present in this beneficial ownership disclosure.

• · The issuer's fiscal year ends March 31
• · The Schedule 13D/A was filed on August 21, 2026, with transactions occurring August 19 and 20, 2026
• · No reportable transactions in the preceding 60 days beyond those listed in Exhibit 99.2

21-08-2026

Erqi Wang, CEO and Chairman of Jin Medical International Ltd., filed a Schedule 13D disclosing beneficial ownership of 5,306,307 Class A ordinary shares (6.77% of the class) as of July 28, 2026, but controlling approximately 98.12% of the company's aggregate voting power through Class B shares with 800 votes each. The filing also reveals a July 21, 2026 recapitalization transaction in which the company repurchased and cancelled 3,769,057 Class A shares from Jolly Harmony for US$6,185,022.54, then issued the same number of Class B shares to Jolly Harmony at the same price, preserving Wang's voting control ahead of an expected issuance of additional Class A shares in connection with the acquisition of Beijing Tongsheng Technology Co., Ltd. The transaction was funded with the repurchase proceeds and involved no borrowed funds.

• · The Schedule 13D was filed because the Reporting Persons' aggregate acquisitions during the preceding twelve months exceeded 2% of the class.
• · Before the recapitalization, Jolly Harmony held 3,769,057 Class A shares and 1,000,000 Class B shares; after the transaction, it held 4,769,057 Class B shares and no Class A shares.
• · Each Class B Ordinary Share is entitled to 800 votes per share and is convertible into one Class A share at the holder's option.
• · The recapitalization was authorized by board and shareholder resolutions; no separate repurchase, subscription, or share issuance agreement was entered into.
• · The purpose of the transactions was to preserve continuity of ownership and voting control by Mr. Wang following the expected issuance of additional Class A shares in connection with the Acquisition.
• · The repurchase and issuance were funded with the proceeds from the repurchase; no borrowed funds were used.
• · A Joint Filing Agreement was entered into on August 21, 2026, among Mr. Wang, Jolly Harmony, and Er Pu International.

21-08-2026

Jane Street Group, LLC filed a Schedule 13G with the SEC on August 21, 2026, disclosing beneficial ownership of 154,512 Class A Ordinary Shares of CDT Environmental Technology Investment Holdings Ltd (CDTG), representing 5.1% of the company's outstanding shares. The filing indicates that Jane Street acquired the shares in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

• · The filing was made under Rule 13d-1(c), indicating the shares were acquired in the ordinary course of business and not to influence control.
• · Jane Street Group, LLC is the parent holding company; its subsidiaries Jane Street Capital, LLC (3.8%) and Jane Street Global Trading, LLC (1.4%) hold portions of the total stake.
• · The filing date is August 21, 2026, with the event date of change as August 17, 2026.
• · The issuer's Class A Ordinary Shares have a par value of $0.0025 per share.

21-08-2026

Jane Street Group, LLC filed a Schedule 13G with the SEC on August 21, 2026, disclosing beneficial ownership of 118,550 Class A Ordinary Shares of Neo-Concept International Group Holdings Ltd (NCI), representing 5.0% of the outstanding shares. The filing indicates that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing includes holdings by subsidiaries Jane Street Capital, LLC (16,912 shares, 0.7%) and Jane Street Global Trading, LLC (101,638 shares, 4.3%).

• · The filing is made under Rule 13d-1(c), indicating the securities were not acquired with the purpose of changing or influencing control.
• · Jane Street Group, LLC is organized under the laws of Delaware.
• · The filing date is August 21, 2026, with the beneficial ownership date as of August 17, 2026.

21-08-2026

Dr. Shao-Lee Lin, CEO and President of Cue Biopharma, filed a Schedule 13D on August 21, 2026, disclosing beneficial ownership of 467,166 shares, representing 6.2% of the company's outstanding common stock. The filing details equity grants tied to her May 2026 appointment as CEO, including a fully-vested RSU award for 327,537 shares, additional RSUs and PSUs, and a trust purchase of pre-funded warrants and warrants for $999,966.

21-08-2026

Bering Partners II, L.P. and its affiliates filed an amended Schedule 13D disclosing beneficial ownership of 3,553,398 shares of CalciMedica, Inc. common stock, representing 9.99% of the outstanding shares as of August 19, 2026. The filing notes that stockholder approval for the issuance of Series A and Series B Warrants was obtained on August 19, 2026, and those warrants were issued the same day. However, the filing also excludes 1,591,300 shares underlying certain Series A and Series B Warrants due to a beneficial ownership limitation that prevents exercise beyond the 9.99% threshold.

• · The filing is an amendment (No. 1) to the original Schedule 13D filed on July 2, 2026.
• · Stockholder approval for the issuance of Series A and Series B Warrants was obtained on August 19, 2026, and the warrants were issued the same day.
• · No transactions in the issuer's securities were effected by the reporting persons within the past 60 days, except as reported.
• · Each reporting person disclaims beneficial ownership of securities except to the extent of their pecuniary interest.

21-08-2026

Almitas Capital LLC filed an amended Schedule 13G with the SEC on August 21, 2026, reporting beneficial ownership of 0 shares of MFS High Yield Municipal Trust (CMU) common stock as of June 30, 2026. The filing indicates that Almitas Capital LLC holds no position in the issuer, representing a 0.0% ownership stake.

• · The filing is an amendment to Schedule 13G, filed under Rule 13d-1(b).
• · Almitas Capital LLC is a Delaware limited liability company and an investment adviser (IA).
• · The filing certifies that the securities were acquired and held in the ordinary course of business, not to change or influence control of the issuer.

21-08-2026

Alexander Rugaev filed a Schedule 13G disclosing beneficial ownership of 2,104,569 ordinary shares of Micropolis AI Robotics (formerly Micropolis Holding Co), representing 5.90% of the 35,653,447 outstanding shares as of August 21, 2026. Rugaev has sole voting and dispositive power over all reported shares, with no shared power. The filing reflects a reduction from the 2,997,000 shares originally issued to him on September 14, 2023, indicating a net decrease of 892,431 shares (approximately 29.8%) over the period.

• · Rugaev's ownership stake is 5.90%, which is below the 10% threshold that typically triggers additional reporting requirements.
• · The filing is made under Rule 13d-1(d), indicating it is a passive investment (not with intent to influence control).
• · The company is incorporated in E9 (likely a foreign jurisdiction) and classified under SIC 3714 (Motor Vehicle Parts & Accessories).

21-08-2026

Almitas Capital LLC filed a Schedule 13G/A with the SEC on August 21, 2026, disclosing that it has ceased to be the beneficial owner of more than 5% of Monroe Capital Corp's common stock. As of June 30, 2026, Almitas Capital reported owning 0 shares (0.0% of the class), down from a prior position that had triggered the filing requirement.

• · The filing is an amendment (Schedule 13G/A) indicating a change in ownership from a prior filing.
• · Almitas Capital LLC is an investment adviser (IA) based in Santa Monica, CA.
• · The filing was made pursuant to Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to influence control.
• · No other reporting persons or joint filers are indicated.

21-08-2026

Almitas Capital LLC filed a Schedule 13G/A with the SEC on August 21, 2026, disclosing a 0.0% beneficial ownership stake in MFS Investment Grade Municipal Trust (CXH) as of June 30, 2026. The filing indicates that Almitas Capital holds no shares of the trust's common stock, reflecting a complete exit from any prior position.

• · Filing type: Schedule 13G/A (amendment to initial 13G)
• · Filing date: August 21, 2026
• · Date of event triggering filing: June 30, 2026
• · Almitas Capital LLC is a Delaware limited liability company, registered as an investment adviser (IA)
• · The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934
• · Almitas Capital certifies the securities were acquired and held in the ordinary course of business, not to change or influence control of the issuer

21-08-2026

Charter Communications, Inc. and its affiliates filed an amended Schedule 13D disclosing beneficial ownership of approximately 63.7% of comScore, Inc.'s common stock on a fully diluted basis (including conversion of Series C Preferred Stock and settlement of deferred RSUs). However, a Certificate of Designations caps conversion of Series C Preferred Stock at 49.99% of outstanding common stock and limits voting rights to 33.32% of common stock on an as-converted basis, effectively restricting Charter's control. The filing also notes shares acquired in connection with a 'Combination' transaction.

• · The filing is Amendment No. 4 to Schedule 13D originally filed March 19, 2021.
• · Charter entities collectively hold 15,090,681 shares on a fully diluted basis, representing 63.7% of comScore's outstanding common stock.
• · Conversion of Series C Preferred Stock is capped at 49.99% of outstanding common stock.
• · Voting rights on Series C Preferred Stock are capped at 33.32% of common stock on an as-converted basis.
• · comScore had 15,184,326 shares of common stock outstanding as of August 10, 2026.
• · The filing references a 'Combination' transaction as defined in Item 4 of the Schedule 13D.

21-08-2026

Yuhe Enterprise Ltd and its sole shareholder Zhibin Su filed a Schedule 13G disclosing beneficial ownership of 5,250 Class A ordinary shares of INLIF Ltd, representing 0.50% of the 1,046,390 shares outstanding as of August 21, 2026. The filing notes that the reporting persons had owned more than 5% as of February 10, 2026, but as of June 30, 2026, they ceased to be beneficial owners of any shares, indicating a complete exit from the position.

• · The shares reflect a 1-for-16 reverse split on April 6, 2026 and a 1-for-200 reverse split on July 6, 2026.
• · Yuhe Enterprise Ltd is incorporated in the British Virgin Islands; Zhibin Su is a citizen of China.
• · The filing is made under Rule 13d-1(c) and includes a joint filing agreement between Yuhe Enterprise Ltd and Zhibin Su.

21-08-2026

Liberty Broadband Corporation filed a final Schedule 13D/A (Amendment No. 14) on August 21, 2026, disclosing that it ceased to be a beneficial owner of more than 5% of Charter Communications' Class A common stock following the completion of a merger on August 19, 2026. As a result, Liberty Broadband now holds zero shares of Charter common stock. Prior to the merger, Liberty Broadband sold 9,900 shares to Charter at $133.86 per share on August 13, 2026, and 129,907 shares at $135.88 per share on July 14, 2026.

• · Liberty Broadband's beneficial ownership dropped from >5% to 0% as of August 19, 2026.
• · The filing is the final amendment (Amendment No. 14) and an exit filing for the Reporting Person.
• · The merger (Combination) closed on August 19, 2026, terminating the Stockholders Agreement.
• · No other transactions in Common Stock by Liberty Broadband occurred in the past 60 days beyond the two sales disclosed.

21-08-2026

TCV entities filed an amended Schedule 13D with the SEC on August 21, 2026, disclosing aggregate beneficial ownership of approximately 14.2% of Nerdy Inc.'s Class A Common Stock as of August 19, 2026. The filing reflects a 1-for-15 reverse stock split effective August 19, 2026, and includes 1,109,101 Opco Units exchangeable for Class A shares. No changes in ownership percentages or control intentions were reported beyond the adjustment for the reverse split.

• · The filing is Amendment No. 3 to the original Schedule 13D filed September 30, 2021.
• · A 1-for-15 reverse stock split of Nerdy Inc. Common Stock became effective August 19, 2026.
• · The outstanding share count of 127,879,473 Class A shares is as of July 31, 2026, per the company's Form 10-Q filed August 6, 2026.
• · All TCV entities disclaim beneficial ownership except for their pecuniary interest.
• · No changes in voting or dispositive power were reported beyond the reverse split adjustment.

21-08-2026

Montanova Capital, LLC and related entities filed a Schedule 13D/A disclosing open market sales and warrant exercises in Veradermics, Inc. On August 19, 2026, the funds sold a total of 750,000 shares at $107.25 per share, and on August 20, 2026, they exercised 300,000 pre-funded warrants at $0.00001 per share. Post-transaction, Montanova Capital and Aaron Cowen each hold 8.8% of the outstanding common stock (3,718,970 shares), while Averill Master Fund holds 7.4% (3,106,937 shares) and Averill Madison Master Fund holds 1.5% (612,033 shares).

• · The filing is Amendment No. 2 to the original Schedule 13D filed on February 11, 2026, and amended by Amendment No. 1 on May 5, 2026.
• · The open market sale occurred on August 19, 2026, and the warrant exercise on August 20, 2026.
• · The warrant exercise price was $0.00001 per share, funded from working capital of the funds.
• · No other transactions in common stock were effected by the reporting persons in the past 60 days except those disclosed.
• · Aaron Cowen disclaims beneficial ownership of shares held by the funds beyond his pecuniary interest.

21-08-2026

GREP GP III, LLC and related Grey Rock entities filed an amended Schedule 13D disclosing a 39.2% beneficial ownership stake in Granite Ridge Resources, Inc. (GRNT) as of August 19, 2026, representing 51,648,048 shares of common stock. This filing updates a prior ownership position following distributions among certain Filing Parties and the termination of the Voting Agreement. While the block remains very large, the disclosure reflects an internal reshuffling of shares—including a reduction from a combined 118,740,242 shares originally issued to the consortium—rather than a new accumulation.

• · The Voting Agreement among the Filing Parties was terminated as part of this amendment.
• · Holdco III-A now directly holds 12,520,096 shares, Holdco III-B holds 28,745,872 shares, and Grey Rock II-C holds 7,810,251 shares.
• · Matthew Miller's direct holdings decreased from 17,175 shares originally to 1,948,266 shares after distribution.
• · Thaddeus Darden's direct holdings decreased from 29,884 shares (including 24,159 via Monticello Avenue LLC) originally to 623,563 shares after distribution.
• · No shares are directly held by GP III-A or GP III-B following the distributions.

21-08-2026

Tang Capital Management LLC and its affiliates (including Kevin Tang) filed a Schedule 13G with the SEC on August 21, 2026, converting their previous Schedule 13D filing to a 13G. The group beneficially owns 19,232,538 ADSs of Nano Dimension Ltd., representing a 9.1% stake (based on 210,839,011 Ordinary Shares outstanding as of August 5, 2026). The filing states the securities are no longer held with the purpose or effect of changing or influencing control of the issuer, signaling a passive investment stance.

• · The filing is Amendment No. 2 to the original Schedule 13D filed on June 30, 2026, as amended on July 27, 2026.
• · The Schedule 13G is being filed under Rule 13d-1(c) and reflects that the Reporting Persons no longer hold securities with a purpose of influencing control.
• · Tang Capital Management LLC is the general partner of TCP and TCPI; Kevin Tang is manager of TCM and CEO of TCP III and TCP IV.
• · TCP III and TCP IV are Nevada corporations indirectly wholly owned by TCP.

21-08-2026

Eric Singer, President, CEO, and Chairman of Immersion Corp, filed a Schedule 13D disclosing beneficial ownership of 1,826,961 shares (5.5% of outstanding shares) as of August 21, 2026. His holdings include 397,825 shares purchased in the open market for $2,408,663 and 1,429,136 shares awarded for his service, with 75,000 shares underlying RSUs vesting within 60 days. The filing also details his compensation package, including a base salary of $1,137,888 in 2025 and a severance agreement providing 300% of base salary and target bonus upon a change of control termination.

• · Eric Singer has sole voting and dispositive power over all 1,826,961 shares.
• · On July 1, 2026, 29,514 shares were withheld to satisfy tax obligations upon vesting of RSUs.
• · No other transactions in Issuer securities by Singer in the past 60 days.
• · Singer's severance agreement provides 300% of base salary and target bonus, plus COBRA for 18 months and full equity acceleration upon involuntary termination before or after a change of control.
• · RSU grants: 450,000 (Jan 2024, 3-year vest), 300,000 (Jan 2025, 2-year vest), 300,000 (Jan 2026, 2-year vest).

21-08-2026

Timothy P. Lynch filed a Schedule 13G with the SEC on August 21, 2026, disclosing beneficial ownership of 6,500,000 shares of AEON Biopharma, Inc. Class A Common Stock, representing 13.0% of the outstanding shares. The filing also notes that Lynch holds prefunded warrants for 1,000,000 shares and milestone warrants for 6,000,000 shares, but these warrants are subject to a 4.99% beneficial ownership limitation and currently cannot be exercised. The percentage is based on 49,882,790 shares outstanding as of August 6, 2026.

• · The filing is made under Rule 13d-1(c), indicating the securities were not acquired to change or influence control of the issuer.
• · Lynch's sole voting and dispositive power covers all 6,500,000 shares.
• · The warrants (prefunded and milestone) are subject to a 4.99% beneficial ownership limitation, preventing current exercise.

21-08-2026

PT Vox Inovasi Nusantara and its director Odi Pratama Aldilah filed a Schedule 13G disclosing beneficial ownership of 252,874 ordinary shares of iOThree Ltd, representing 8.34% of the 3,032,199 outstanding shares as of July 20, 2026. The filing indicates passive investment intent under Rule 13d-1(c).

• · The filing is a Schedule 13G, indicating passive investment intent (not activist).
• · The reporting persons are PT Vox Inovasi Nusantara (Indonesian company) and Odi Pratama Aldilah (individual).
• · The filing includes a joint filing agreement between the two reporting persons.

21-08-2026

Hyperscale Data, Inc. and its affiliates, including Ault Lending, LLC and Milton C. Ault III, collectively hold approximately 38.1% of Universal Safety Products, Inc. (UUU) common stock as of August 21, 2026. In the week leading up to the filing, the group made significant open-market purchases totaling over 69,000 shares at prices ranging from $3.83 to $6.37 per share, indicating strong buying activity. However, the filing also shows that Ault & Company, Inc. holds only 6,200 shares (less than 1%), and Henry C. Nisser holds options for 25,000 shares (less than 1%), representing minimal direct stakes from these entities.

• · The filing is Amendment No. 18 to the original Schedule 13D filed December 23, 2024.
• · Ault Lending purchased 300,000 shares from JLA Realty Associates LLC on January 16, 2026 for $1,800,000 via promissory notes.
• · Ault Lending purchased 340,000 shares from SJC Lending, LLC on April 30, 2026 (amended May 15, 2026) for $1,955,000 via promissory notes.
• · Milton C. Ault III and Henry C. Nisser each hold director stock options for 50,000 and 25,000 shares respectively, with a strike price of $3.40 per share, expiring August 26, 2035, all vested as of October 20, 2025.
• · No transactions were reported by any reporting person since Amendment No. 17 except those listed in Exhibit 1.
• · Ault Lending's recent purchases (Aug 17-21, 2026) totaled 61,281 shares at prices from $4.09 to $6.34 per share.
• · Milton C. Ault III's recent purchases (Aug 17-21, 2026) totaled 4,500 shares at prices from $3.83 to $6.37 per share.
• · Alpha Structured Finance LP's recent purchases (Aug 17 & 20, 2026) totaled 2,700 shares at prices from $4.12 to $6.07 per share.

21-08-2026

Ron Sade filed Amendment No. 2 to Schedule 13D, reporting that the informal group of reporting persons has disbanded and each member now beneficially owns less than 5% of Brera Holdings PLC's outstanding Class B Ordinary Shares. The filing serves as an exit filing for all reporting persons. Key transactions include Mr. Sade's sale of 21,164 shares at $35.00 per share on September 19, 2025, for proceeds of $740,740, and other sales by group members, while Ms. Maimon agreed to sell 44,444 shares and warrants to two other individuals for approximately $200,000 each.

• · The group disbanded effective September 23, 2025, and each member now holds less than 5% of outstanding shares.
• · Share numbers do not reflect the 1-for-10 reverse share split of Ordinary Shares on April 7, 2026.
• · Mr. Sade, Ms. Maimon, Ms. Almheiri, and Mr. Alnuaimi were appointed to the Board of Directors on the Event Date (September 23, 2025).
• · Ms. Maimon sold 44,444 shares and 44,444 warrants to Ms. Almheiri for ~$200,000, and the same to Mr. Alnuaimi for ~$200,000.

21-08-2026

Sky Frontier Foundation filed Amendment No. 2 to Schedule 13D, disclosing that as of August 17, 2026, the second tranche of its Warrant (6,000,000 shares) became exercisable within 60 days, bringing total exercisable shares to 10,000,000. However, due to a 9.99% beneficial ownership limitation, the Reporting Person is deemed to beneficially own only 5,617,689 shares (9.99% of outstanding common stock). The Reporting Person has not exercised any portion of the Warrant and holds no shares directly.

• · The Reporting Person has not exercised any portion of the Warrant and holds no shares of Common Stock directly.
• · The beneficial ownership change resulted solely from the second tranche of the Warrant becoming exercisable within 60 days, not from any acquisition or disposition.
• · The Reporting Person disclaims beneficial ownership of any shares issuable upon exercise of the Warrant in excess of the 9.99% beneficial ownership limitation.
• · Upon exercise, the Reporting Person will have sole voting and dispositive power over the 5,617,689 shares.

21-08-2026

Westerly Capital Management, LLC, along with related entities Christopher J. Galvin and Westerly Holdings LLC, filed an amended Schedule 13G with the SEC on August 21, 2026, reporting that they collectively own 0 shares of Harte Hanks Inc. common stock as of August 19, 2026. This represents a complete exit of their previously held position in the company.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.
• · The filers certify that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

21-08-2026

BlackRock, Inc. filed a Schedule 13G with the SEC on August 21, 2026, disclosing beneficial ownership of 1,236 shares of Lincoln National Corp's Series D Preferred Stock, representing 6.2% of the outstanding shares of that class. The filing is made under Rule 13d-1(b) and indicates the securities were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(b), indicating passive investment intent.
• · BlackRock's beneficial ownership includes 1,236 shares with sole voting power and sole dispositive power over all 1,236 shares.
• · The iShares Preferred and Income Securities ETF, a BlackRock entity, holds more than 5% of the Series D Preferred Stock.
• · The filing includes a power of attorney dated January 21, 2025, authorizing multiple individuals to execute regulatory filings on behalf of BlackRock.

21-08-2026

Exor N.V. and Giovanni Agnelli B.V. filed Amendment No. 4 to their Schedule 13D with the SEC, disclosing that on August 10, 2026, Koninklijke Philips NV and Exor amended their Relationship Agreement to increase the ownership limit from 20.0% to 22.0% of Philips' outstanding ordinary shares and voting rights. The Reporting Persons collectively hold 185,932,684 ordinary shares, representing 19.03% of the outstanding shares, unchanged from prior filings. No transactions in the shares were effected by the Reporting Persons during the past 60 days.

• · The Amended Relationship Agreement increased the ownership limit from 20.0% to 22.0% of Philips' outstanding ordinary shares and voting rights.
• · No transactions in the shares were effected by the Reporting Persons during the past 60 days.
• · Neither the Reporting Persons nor any listed persons have the right to receive or direct the receipt of dividends or proceeds from the sale of the securities.

21-08-2026

Richard Ogawa filed a Schedule 13D/A disclosing his beneficial ownership of 1,882,500 shares (6.9%) of Palomino Laboratories Inc. The filing reports that on July 31, 2026, Palomino acquired Vega Links, Inc. (VLI) via a share exchange, issuing 4,472,000 shares of Palomino common stock in exchange for all 11,180,000 VLI shares. As part of this acquisition, Ogawa, a VLI shareholder who also serves as Secretary and a director of Palomino, received 120,000 Palomino shares for his 300,000 VLI shares; his total beneficial ownership includes 125,000 shares issuable upon warrant exercise. No other transactions in Palomino shares were reported in the past 60 days.

• · Ogawa's 1,882,500 shares include 125,000 shares issuable upon exercise of a warrant.
• · The Consideration Shares are subject to vesting per Ogawa's existing stock purchase agreement with VLI.
• · No other transactions in Palomino shares by Ogawa in the past 60 days.
• · Ogawa may have influence over corporate activities due to his roles as Secretary and director.

21-08-2026

The Loewenbaum family group (Reporting Persons) filed an amended Schedule 13D disclosing aggregate beneficial ownership of 5,140,580 ordinary shares of CollPlant Biotechnologies, representing 24.99% of the outstanding shares (including shares issuable upon warrant exercise within 60 days). The filing reflects the removal of Nachum Shamir, Patrick Chalmers, and Reginald J. Hargrove from the group, and details a June 29, 2026 Securities Purchase Agreement under which The Loewenbaum 1992 Trust purchased 1,764,706 ordinary shares, Series A Warrants for 1,764,706 shares ($0.34 exercise price, expiring July 16, 2028), and Series B Warrants for 3,529,412 shares ($0.34 exercise price, expiring July 16, 2031). The group's holdings are subject to a 24.99% beneficial ownership limitation.

• · Effective August 19, 2026, Nachum Shamir confirmed he is not acting as a group with the Reporting Persons; his holdings were removed from the filing.
• · Effective August 20, 2026, Patrick Chalmers and Reginald J. Hargrove confirmed they are not acting as a group; their holdings were removed.
• · The Loewenbaum 1992 Trust transferred funds equal to the aggregate exercise price of the Series B Warrants on August 20, 2026, but no warrants were exercised; funds are held in abeyance.
• · Series A Warrants expire on July 16, 2028; Series B Warrants expire on July 16, 2031.
• · The Reporting Persons have no present plan or proposal for any of the actions specified in Item 4 of Schedule 13D.